Welcome MOCA

We see cannabis as the flower of life, that continuously unfolds revealing healing and therapeutic properties.  
Our Vision is a world where wellness abounds and cannabis is used as a means to alleviate pain and suffering to boost health and promote well-being.

At Medicinal Organic Cannabis we seek to become a global leader in the development, commercialization and research of state-of the-art organic cannabinoid based therapeutic products for a variety of clinical indications. 

MOCA is strategically positioned to be a key player in the medicinal organic cannabis market.

Introduction

In 1964 Israel scientist Dr. Raphael Mechoulam was able to identify and isolate tetrahydrocannobinol (THC) and cannabidiol (CBD) from the Cannabis plant for the first time. This landmark scientific discovery of being able to isolate these cannabinoids for the first time was the first stepping stone in discovering the endocannabinoid system, a biological system that can be found in just about any living thing with vertebrae.  

There are approximately 500 natural components found within the cannabis sativa plant, of which up to 100 have been classified as ‘cannabinoids’; chemicals unique to the plant. The cannabinoids are most abundant in the un-fertilised female flower head and this is the part of the plant utilised in the development of medicinal cannabis products.

The most well-known of the cannabinoids is delta-9-tetrahydrocannobinol (THC). It was isolated in 1964 in Israel. This cannabinoid is responsible for the psychoactive effects of cannabis and is the reason cannabis is used recreationally. 

However, it appears that THC may also be responsible for some of the medicinal effects of cannabis such as reduction of nausea, vomiting, pain and muscle spasms as well as improvement in sleep and appetite.

“By using a plant that has been around for thousands of years, we discovered a new physiological system of immense importance,” says Raphael Mechoulam, the dean of the transnational cannabinoid research community. “We wouldn’t have been able to get there if we had not looked at the plant.”

The human body has an endocannabinoid system that makes cannabis-like substances that affect pain, inflammation, and many other processes. It’s perhaps the most important physiologic system involved in maintaining human health. While the cannabinoid system performs different functions in each area of the body, experts believe its main role is to regulate homeostasis, the process that maintains the stability of the body’s internal environment in response to changes in external conditions. 

The Case for Medical Cannabis in Canada

Beginning in 2001 the Government of Canada formally recognized the medical benefits of cannabis by enacting legislation (MMAR) to:- 

“Establish a framework to allow access to marijuana by individuals suffering from grave or debilitating illnesses, where conventional treatments are inappropriate or are not providing adequate relief.”  

The government based this ground-breaking legislation based on a preponderance of medical evidence surrounding the use of medicinal cannabis.

The medical cannabis industry in Canada has flourished as regulated growers and producers increase supply to meet the ever-growing international demand as patient awareness for cannabis based medications become readily available to consumers.

Changes to Legislation regarding Cannabis in Australia

In October of 2016, the Australian Minister for Health and Aged Care and Minister for Sport The Hon. Susan Ley MP announced that the commencement of the Narcotics Drugs Amendment Act 2016 will give patients and doctors access to safe, reliable and legal source of cannabis for medicinal use. 

Businesses in Australia can now apply for a licence to cultivate Cannabis for medicinal purposes, to manufacture medicinal cannabis products or to conduct medicinal cannabis related research under the Medicinal Cannabis Scheme. 

“It is important that doctors have a wider range of options for treating their patients,” Minister Ley said.  “Until now, it has been difficult for patients to access medicinal cannabis products from overseas sources. These new laws change that situation by providing for a domestic supply of medicinal cannabis that are not readily available for import.  

Medicinal Organic Cannabis Australia (MOCA) 

Medicinal Organic Cannabis Australia (MOCA) is an Australian Company seeking licences to undertake research, importation, production and to cultivate cannabis for human medicinal purposes under the Australian Government’s new medical cannabis regulatory system.

MOCA has coordinated an interdisciplinary cross-functional team to establish the requirements, evaluate alternatives, develop the business case and implement the solution. The highly skilled and experienced management team has developed an appropriate strategy to build the capabilities and collaborative relationships necessary to capitalise on the opportunities emerging in the medicinal cannabis industry.

MOCA’s points of differentiation include the use of indoor cultivation in controlled environments optimizing space by using vertical garden systems, utilizing a combination of hydroponic and aquaponic  systems designed to create medicinal organic cannabis products for local and international market supply.
Philosophy
The Flower of Life is an ancient symbol which can be found in cultures throughout the world. From the beginning of time in human civilization, this symbol has been present. Sites in Egypt, Asia in many countries have relevance to this symbol is the basis for sacred geometry and you can read more about the flower of life on this link. MOCA has selected this logo as it reflects the philosophy and way of operations in the medical cannabis 

Mission 

  1. To become a global leader in the development, commercialization and research of state-of the-art organic cannabinoid based therapeutic products for a variety of clinical indications. 
  2. To become a grower and supplier of unique strains of organic cannabis, whether independently or by partnering with others and to supply established, existing and newly regulated markets.
Vision

We see cannabis as the flower of life that continuously unfolds revealing healing and therapeutic properties.  

Our Vision is a world where wellness abounds and cannabis is used as a means to alleviate pain and suffering to boost health and promote well being.

Company Objectives 

  • MOCA is strategically positioned to be a key player in the medicinal organic cannabis Australian market.
  • MOCA’s focus is to create a facility in Australia for Medicinal Cannabis production and research.
  • MOCA aims to operationalize the facility and technology in cultivating, producing and researching medicinal cannabis to produce high yield cannabis.
  • The company plans on developing onsite processing for extraction of cannabis oil and production of medical grade cannabis products.